Credence Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 26-07-2024
- Paid Up Capital ₹ 2.50 M
as on 26-07-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.70 Cr
as on 26-07-2024
- Satisfied Charges ₹ 4.25 Cr
as on 26-07-2024
- Revenue 18.15%
(FY 2023)
- Profit -79.90%
(FY 2023)
- Ebitda -9.88%
(FY 2023)
- Net Worth 2.15%
(FY 2023)
- Total Assets 20.51%
(FY 2023)
About Credence Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.70 Cr. The company has closed loans amounting to ₹4.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pallavi Sule, Amol Sule, Avinash Karkhanis, and One other member serve as directors at the Company.
- CIN/LLPIN
U85191MH2011PTC223844
- Company No.
223844
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Credence Remedies Private Limited offer?
Credence Remedies Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Dietary Supplements, Film & Media Production Services, Short Film Services, Gold & Gold Jewellery, Gold Bullion.
Who are the key members and board of directors at Credence Remedies?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amol Sule | Director | 12-Nov-2011 | Current |
Pallavi Sule | Director | 12-Nov-2011 | Current |
Avinash Karkhanis | Director | 08-Nov-2019 | Current |
Dharam Tripathi | Additional Director | 03-May-2024 | Current |
Financial Performance of Credence Remedies.
Credence Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.15% increase. The company also saw a substantial fall in profitability, with a 79.9% decrease in profit. The company's net worth moved up by a moderate rise of 2.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Credence Remedies?
In 2023, Credence Remedies had a promoter holding of 90.40% and a public holding of 9.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Keyur Animal Healthcare Private LimitedActive 4 years 2 months
Pallavi Sule and Amol Sule are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 03 Aug 2020 | ₹4.00 M | Open |
Others Creation Date: 09 Jun 2020 | ₹2.00 M | Open |
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 30 Mar 2017 | ₹8.50 M | Open |
How Many Employees Work at Credence Remedies?
Credence Remedies has a workforce of 14 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Credence Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Credence Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.